Transmural healing is not associated with less disability than complete endoscopic mucosal healing: a prospective study in a patient with Crohn's disease

Author:

Yzet Clara1,Brazier Franck1,Hautefeuille Vincent1,Grados Lucien1,Richard Nicolas2,Decrombecque Catherine1,Diouf Momar1,Fumery Mathurin1

Affiliation:

1. Amiens University Hospital

2. Rouen University Hospital

Abstract

Abstract Introduction: Crohn's disease (CD) is associated with disability by affecting physical and emotional well-being, and by altering social interactions. The impact of transmural healing on disability is currently unknown. Methods We conducted a monocentric cross-sectional study. Patients followed for CD in endoscopic remission (CDEIS < 4) underwent within < 4 weeks an intestinal ultrasound (IUS) and a disability assessment by an IBD-disk and were consecutively included. Four groups were considered: (A) transmural healing defined by the combination of complete endoscopic healing (CDEIS = 0) and ultrasound healing (bowel wall thickness (BWT) less than 3 mm), (B) complete endoscopic healing, (C) ultrasound healing and (D) Partial healing. Moderate to severe disability was defined as an overall score ≥ 40. Results A total of 85 patients were included. Forty-four (51.7%) were female, the median age and disease duration were 38 years ([IQR], 33–44) and 12.0 years (IQR, 5–20). The median global IBD-Disk score was 25 (IQR, 9–41) and 24 patients (28.2%) had moderate to severe disability. Transmural healing (group A) was observed in 40 patients (47.1%). Moderate to severe disability was identified in 17.5% (7/40) of patients with transmural healing, 25% (4/16) with endoscopic healing, 44.4% (8/18) with ultrasound healing and 45.4% (5/11) without healing. There was no difference in terms of severe disability between patients with transmural healing and complete endoscopic healing (group B versus A OR = 1.5 95% CI [0.3, 6.2], p = 0.525) Conclusions Transmural healing did not provide any benefit in terms of disability compared to complete endoscopic healing.

Publisher

Research Square Platform LLC

Reference18 articles.

1. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD;Turner D;Gastroenterology,2021

2. Bowel damage and disability in Crohn’s disease: a prospective study in a tertiary referral centre of the Lémann Index and Inflammatory Bowel Disease Disability Index;Lauriot dit Prevost C;Aliment Pharmacol Ther,2020

3. Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients;Marinelli C;Gastroenterology Research and Practice,2019

4. Costa JM, Matos D, Arroja B, Gon࿽alves R, Soares JB. The main determinants of disability in IBD and its relationship to optimism. Rev Esp Enferm Dig [Internet]. 2019 [cited 2021 Mar 21];111. Available from: https://online.reed.es/fichaArticulo.aspx?iarf=685761745239-415273194167

5. Health Care Indicators of Moderate to Severe IBD and Subsequent IBD-Related Disability: A Longitudinal Study;Shafer LA;Inflammatory Bowel Diseases,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3